Hound Partners, LLC Liquidia Corp Transaction History
Hound Partners, LLC
- $307 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding LQDA
# of Institutions
168Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$103 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$60.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$49.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$47.2 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$45.8 Million16.08% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $922M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...